Braskem S.A. (NYSE:BAK - Get Free Report) shares traded up 3.9% during trading on Thursday . The stock traded as high as $3.64 and last traded at $3.62. 488,331 shares traded hands during mid-day trading, a decline of 40% from the average session volume of 818,246 shares. The stock had previously closed at $3.48.
Analyst Ratings Changes
Separately, Scotiabank cut Braskem from a "sector outperform" rating to a "sector perform" rating in a research report on Monday, March 3rd.
Read Our Latest Report on BAK
Braskem Price Performance
The business's 50 day moving average price is $4.23 and its 200 day moving average price is $5.27. The firm has a market cap of $1.44 billion, a PE ratio of -1.02 and a beta of 2.06.
Braskem (NYSE:BAK - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported ($0.39) EPS for the quarter, missing the consensus estimate of ($0.38) by ($0.01). The firm had revenue of $3.28 billion for the quarter, compared to analysts' expectations of $3.52 billion. Braskem had a negative return on equity of 439.59% and a negative net margin of 9.88%. As a group, analysts predict that Braskem S.A. will post -0.77 earnings per share for the current year.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. grew its holdings in shares of Braskem by 876.1% during the third quarter. JPMorgan Chase & Co. now owns 5,427 shares of the company's stock worth $40,000 after buying an additional 4,871 shares in the last quarter. R Squared Ltd acquired a new position in Braskem during the fourth quarter worth about $44,000. Blue Trust Inc. grew its stake in Braskem by 2,510.3% during the 4th quarter. Blue Trust Inc. now owns 13,130 shares of the company's stock valued at $51,000 after acquiring an additional 12,627 shares in the last quarter. Signaturefd LLC acquired a new stake in Braskem in the 4th quarter valued at about $53,000. Finally, Dark Forest Capital Management LP purchased a new position in Braskem in the 4th quarter worth approximately $71,000.
About Braskem
(
Get Free Report)
Braskem SA, together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Braskem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Braskem wasn't on the list.
While Braskem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
